Cellbyte raises $2.75m to fund pharma drug launch platform

Esme Needham | November 27, 2025 | News story | Product launch AI, Cellbyte, biotech 

Cellbyte has announced that it has raised $2.75m in seed funding for the streamlining of pharmaceutical drug launches.

The complexity of steps such as pricing and reimbursement strategies, regulatory approval and data collection means that novel, life-saving drugs can take over a year to reach the patients who need them. Pharmaceutical companies often spend hundreds of thousands of dollars to access and complete market data in advance of a drug launch. Cellbyte’s AI-native platform, however, is designed to allow drug launch teams to rapidly analyse millions of data points. It aims to determine the most effective launch sequences and market strategies, reducing cost, time and labour.

Cellbyte’s goal is to replace outdated legacy databases, reducing data processes that previously took up to a year to a matter of minutes without loss of quality.

Advertisement

“I’ve seen countless innovations transforming clinical development. Yet in pricing and market access, decisions still too often rely on manual work and anecdotal evidence even though information is so abundant. Now, generative AI is changing that,” said Daniel Moreira, co-CEO and co-founder at Cellbyte.

Felix Steinbrenner, co-CEO and co-founder at Cellbyte, said: “The industry is ready to rethink drug launch workflows and adopt faster, higher quality and cost-effective processes.”

Related Content

Bramacare launches new AI platform to improve eating disorder care

Bramacare has launched an AI-enabled platform designed to aid eating disorder and rehabilitation services, the …

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

Roche has expanded its global AI infrastructure with a NVIDIA AI factory, adding 2,176 high-performance …

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

Arkin Capital has announced the closing of Arkin Bio Ventures III, a $100m fund designed …

The Gateway to Local Adoption Series

Latest content